How much for a star? Elements for a rational choice of sample size in preclinical trials

Author： Haimez C.   Groupe Biopharmacie et Sante de la Societe Francaise de Statistique Good preclinical statistical practices working party  

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.23, Iss.5, 2002-05, pp. : 221-225

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sample Size Determination for Cost-Effectiveness Trials

By Willan Andrew R.  

PharmacoEconomics, Vol. 29, Iss. 11, 2011-11 ,pp. : 933-949

Adis International

Access to resources Recommend Favorite

On Cost Effectiveness and Sample Size in Clinical Trials

By Augustinus A.M. Hart   Marcel G.W. Dijkgraaf  

PharmacoEconomics, Vol. 22, Iss. 10, 2004-01 ,pp. : 685-688

Adis International

Access to resources Recommend Favorite

How Much Missing May Be Too Much in Clinical Trials of Neuropharmacological Drug Products

By  

Applied Clinical Research, Clinical Trials and Regulatory Affairs, Vol. 1, Iss. 3, 2014-12 ,pp. : 125-134

Bentham Science Publishers

Access to resources Recommend Favorite

Calculation of Tolerance Limits and Sample Size Determination for Clinical Trials with Dichotomous Outcomes

By Zaslavsky Boris G.  

Journal of Biopharmaceutical Statistics, Vol. 17, Iss. 3, 2007-05 ,pp. : 481-491

Taylor & Francis Ltd

Access to resources Recommend Favorite

Sample Size Re-Estimation for Adaptive Sequential Design in Clinical Trials

By Gao Ping  

Journal of Biopharmaceutical Statistics, Vol. 18, Iss. 6, 2008-11 ,pp. : 1184-1196

Taylor & Francis Ltd

Access to resources Recommend Favorite